Clinical trial

PET/CT (Positron Emission Tomography/Computed Tomography) Imaging for Safety and Tolerability and Diagnostic Performance of BAY1075553 in Patients With Prostate Cancer and Healthy Volunteers

NCT01287845

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-02-01

PhasePHASE1

Study timeline

Study start (unknown)2011-02-01Date precision: month

Registry last updated2013-01-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diagnostic Imagingunresolved

Interventions

BAY1075553DRUG

Sponsors & collaborators

Lantheus Biosciences Ltd.lead sponsor

Mapped research locations

Ann ArborMichigan, United States1 LinzAustria1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01287845 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.